Lew D - Search Results

1

Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point.

Small EJ, Lew D, Redman BG, Petrylak DP, Hammond N, Gross HM, Eastham JA, Crawford ED. Small EJ, et al. Among authors: lew d. J Clin Oncol. 2000 Jul;18(13):2537-44. doi: 10.1200/JCO.2000.18.13.2537. J Clin Oncol. 2000. PMID: 10893284 Clinical Trial.

2

Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124).

Meyers FJ, Lew D, Lara PN Jr, Williamson S, Marshall E, Balcerzak SP, Rivkin SE, Samlowski W, Crawford ED. Meyers FJ, et al. Among authors: lew d. Invest New Drugs. 1998-1999;16(4):347-51. doi: 10.1023/a:1006128024879. Invest New Drugs. 1998. PMID: 10426670 Clinical Trial.

3

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.

Williamson SK, Lew D, Miller GJ, Balcerzak SP, Baker LH, Crawford ED. Williamson SK, et al. Among authors: lew d. Cancer. 2000 Mar 1;88(5):1159-65. Cancer. 2000. PMID: 10699907 Clinical Trial.

4

Phase II evaluation of suramin in advanced renal cell carcinoma. A Southwest Oncology Group study.

Schroder LE, Lew D, Flanigan RC, Eisenberger MA, Seay TE, Hammond N, Needles BM, Crawford ED. Schroder LE, et al. Among authors: lew d. Urol Oncol. 2001 Jul;6(4):145-148. doi: 10.1016/s1078-1439(00)00126-5. Urol Oncol. 2001. PMID: 11418320

5

Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study.

Whitehead RP, Lew D, Flanigan RC, Weiss GR, Roy V, Glode ML, Dakhil SR, Crawford ED. Whitehead RP, et al. Among authors: lew d. J Immunother. 2002 Jul-Aug;25(4):352-8. doi: 10.1097/00002371-200207000-00007. J Immunother. 2002. PMID: 12142558 Clinical Trial.

6

Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer.

Pierce LJ, Hutchins LF, Green SR, Lew DL, Gralow JR, Livingston RB, Osborne CK, Albain KS. Pierce LJ, et al. J Clin Oncol. 2005 Jan 1;23(1):24-9. doi: 10.1200/JCO.2005.01.198. Epub 2004 Nov 15. J Clin Oncol. 2005. PMID: 15545669 Clinical Trial.

7

SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.

Budd GT, Barlow WE, Moore HC, Hobday TJ, Stewart JA, Isaacs C, Salim M, Cho JK, Rinn KJ, Albain KS, Chew HK, Burton GV, Moore TD, Srkalovic G, McGregor BA, Flaherty LE, Livingston RB, Lew DL, Gralow JR, Hortobagyi GN. Budd GT, et al. Among authors: lew dl. J Clin Oncol. 2015 Jan 1;33(1):58-64. doi: 10.1200/JCO.2014.56.3296. Epub 2014 Nov 24. J Clin Oncol. 2015. PMID: 25422488 Free PMC article. Clinical Trial.

8

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.

Moore HC, Green SJ, Gralow JR, Bearman SI, Lew D, Barlow WE, Hudis C, Wolff AC, Ingle JN, Chew HK, Elias AD, Livingston RB, Martino S; Southwest Oncology Group/Intergroup Study 9623. Moore HC, et al. Among authors: lew d. J Clin Oncol. 2007 May 1;25(13):1677-82. doi: 10.1200/JCO.2006.08.9383. Epub 2007 Apr 2. J Clin Oncol. 2007. PMID: 17404368 Clinical Trial.

9

Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.

Velasquez WS, Lew D, Grogan TM, Spiridonidis CH, Balcerzak SP, Dakhil SR, Miller TP, Lanier KS, Chapman RA, Fisher RI; Southwest Oncology Group. Velasquez WS, et al. Among authors: lew d. J Clin Oncol. 2003 May 15;21(10):1996-2003. doi: 10.1200/JCO.2003.09.047. J Clin Oncol. 2003. PMID: 12743154 Clinical Trial.

10

Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).

Linden HM, Haskell CM, Green SJ, Osborne CK, Sledge GW Jr, Shapiro CL, Ingle JN, Lew D, Hutchins LF, Livingston RB, Martino S. Linden HM, et al. Among authors: lew d. J Clin Oncol. 2007 Feb 20;25(6):656-61. doi: 10.1200/JCO.2006.07.0847. J Clin Oncol. 2007. PMID: 17308269 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

804 results

Search Page